Micro-x Ltd. · ASX:MX1
Micro-x — Shareholder Meeting (November 2023)
20 slides from Micro-x's shareholder meeting presentation, Nov 30, 2023
Slide 1: 2023 AGM CEO Presentation
For personal use only 2023 AGM C E O P R E S E N TAT I O N Kingsley Hall Chief Executive Officer Micro-X Annual General Meeting 2023 I 1
Slide 2: Important Notice
I M P O RTA N T N OT I C E For personal use only S C O P E & L I M I T A T I O N S This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not contain all the information about the Company’s assets and liabilities, financ
Slide 3: Creating Revolutionary Imaging to Better Lives
For personal use only C R E AT I N G R E V O L U T I O N A R Y I M A G I N G TO BETTER LIVES Commercialisation I Te c h n o l o g y I People Micro-X Annual General Meeting 2023 I 3
Slide 4: The Future of X-Ray
T H E F U T U R E O F X - R AY Smaller, lighter, reliable For personal use only Lighter Same platform, multiple applications No heat Micro-X proprietary Nano Electronic Very fast pulse control (NEX) Technology - carbon nanotube emitter made of millions of nanotubes emitting digitally Smaller control
Slide 5: Four Innovative Products
F O U R I N N O VAT I V E P R O D U C T S Each product drives a different utilisation of Micro-X’s world leading technology For personal use only Mobile Digital Radiology Argus X-ray Camera Checkpoints & Baggage Scanner Brain CT Lightweight and ultra-mobile x-ray World first high-definition bomb ima
Slide 6: FY2023 Highlights
FY2023 HIGHLIGHTS Key development milestones achieved laying the foundation for future commercialisation For personal use only Leadership transition $15m revenues ↑67% $15m strategic collaboration Strengthened commercial focus $3.8m product sales and $11.2m in paid Varex Imaging - world’s largest x-
Slide 7: 2024 – Recent Progress
2024 – RECENT PROGRESS New leadership delivering on strategic objectives For personal use only $2.9m Q1 sales [FY23 $3.8m] Argus pipeline $21m DHS contract ext. More focused approach to customers and Multiple customer engagements and US Dept of Homeland Security for Airport delivery into new segment
Slide 8: Product Portfolio
For personal use only PRODUCT PORTFOLIO L e v e r a g i n g p r o p r i e t a r y N E X Te c h n o l o g y
Slide 9: Mobile DR
MOBILE DR First product to market validating revolutionary technology For personal use only Distinct product advantages and range of uses → Smaller, more mobile, full range of imaging applications → Meets hospital mobile imaging requirements and military needs → Applications in elite sports and vete
Slide 10: Argus X-Ray Camera
A R G U S X - R AY C A M E R A Saving lives by redefining bomb detection For personal use only Unique product advantages and range → Stand-off detection of potential bomb threats or IEDs – removes operator from threat → One sided imaging enables imaging of otherwise inaccessible targets → Only robot
Slide 11: Argus X-Ray Camera
A R G U S X - R AY C A M E R A Saving lives by redefining bomb detection For personal use only The video played at today’s AGM will be available on the Company’s website 1,500m+ Range of remote operation US$1.8b Market Micro-X Annual General Meeting 2023 I 11
Slide 12: Checkpoints
CHECKPOINTS Next generation self-service security screening For personal use only Significant advantages for travellers + airports → Faster – Passenger screening in 30 seconds, 8 passengers screened simultaneously. → Safer – Passenger, baggage, and Identification combined with AI to increase detecti
Slide 13: DHS Checkpoints Project
DHS CHECKPOINTS PROJECT The DHS Checkpoints contract extension marks the next stage in full commercialisation For personal use only Critical Design Review $21m Contract Phase 1 Phases 2-8 Gate Passed Extension Awarded Initial prototype build Fabrication of 6 units and live testing June July 18 22 20
Slide 14: Brain CT
BRAIN CT Taking stroke diagnosis from the hospital to the ambulance For personal use only Saving lives with stroke diagnosis in any ambulance → Mobile – 70kg unit suitable for all road and air ambulances → Accurate – 8 second scan for 3D imaging down to 0.5ml blood → Enabler – Life saving response t
Slide 15: Driving Commercial Success
For personal use only DRIVING COMMERCIAL SUCCESS B u i l d i n g a b u s i n e s s n o t j u s t a t e c h n o l o g y
Slide 16: Our Strategy
O U R S T R AT E G Y Creating a profitable business with our world class technology For personal use only 01 02 03 Commercial skills Sweat the asset Target larger and - Commercially driven - Leverage our technology less competitive markets Building commercial skills - prioritising commercial Created
Slide 17: Partners for Growth
PA R T N E R S F O R G R O W T H De-risking development and unlocking value from our Technology For personal use only Development Partner Development Partner Licensing Partner Leading technology Checkpoints - $28m funding Brain CT - $8m funding Multibeam Emitters - $15m Transform the passenger secur
Slide 18: Revenue Timeline
REVENUE TIMELINE Commercialising four revenue generating product lines by 2026 For personal use only Revenue Timeline Division Sector Products Commercial Status 2023 2024 2025 2026 Next major milestone $3.8m Revenue – FY23 CE Mark Mobile DR Healthcare FDA and TGA Sales in Europe Sales in Europe 350+
Slide 19: Corporate & Financials
C O R P O R AT E For personal use only & FINANCIALS FINANCIALS & SHAREHOLDERS SHARE CAPITAL (28 November 2023) ~A$1.3m (30 September 2023) Cash Share price $0.12 per share Committed cash inflows + $7.2m received October 2023 - $8.9m committed Dec 23 & March 24 Revenue A$15.0m (FY2023) +67% Total sha
Slide 20: Summary
S U M M A RY Pioneers in carbon nanotube x-ray technology For personal use only Creating revolutionary imaging to better lives → Pioneers in proprietary carbon nanotube X-ray technology – Nano Electronic X-ray (NEX) → Innovative product portfolio spanning healthcare and security applications Platfor